Atria Investments’s CalciMedica CALC Stock Holding History

Atria Investments’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,756	Closed	-$190K	–	2052
2025 Q4	$190K	Sell	5,756 -1,861	-24%	-$36.3K	﹤0.01%	1977
2025 Q3	$117K	Sell	7,617 -1,323	-15%	-$19K	﹤0.01%	1985
2025 Q2	$71.5K	Buy	8,940 +1,487	+20%	+$12.8K	﹤0.01%	1972
2025 Q1	$71.2K	Buy	7,453 +651	+10%	+$8.11K	﹤0.01%	1879
2024 Q4	$120K	Buy	6,802 +1,501	+28%	+$26.3K	﹤0.01%	1823
2024 Q3	$117K	Buy	5,301 +3,060	+137%	+$67.2K	﹤0.01%	1865
2024 Q2	$44.4K	Buy	+2,241	New	+$56.5K	﹤0.01%	1893

Other funds holding CALC

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Atria Investments's CALC Position: Q1 2026 in Review

Atria Investments sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 5,756 shares — an estimated $190K sold.

Atria Investments first reported a position in CALC in Q2 2024 and held it in 7 quarters. The position peaked at $190K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Atria Investments reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
Atria Investments sold 5,756 CalciMedica shares in Q1 2026, an estimated $190K.
Atria Investments first reported a position in CalciMedica in Q2 2024 and held it in 7 quarters.
Atria Investments's CalciMedica position peaked at $190K in Q4 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.